FDA permits marketing of first non-drug treatment for ADHD
The device generates a low-level electrical pulse and connects via a wire to a small patch that adheres to a patient’s forehead.
Read More
Tag: Monarch external Trigeminal Nerve Stimulation
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
